Real-time enrollment status for this cll clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 7:59 AM UTC
| NCT Number | NCT06697184 |
| Recruiting Status | Recruiting |
| Condition | CLL |
| Phase | PHASE1 |
| Target Enrollment | 258 participants |
| Active Locations | 6 sites in the US |
| Sponsor | BeiGene |
| Last Updated on CT.gov | June 8, 2026 (Jun 8, 2026) |
As of July 19, 2026: Clinical trial NCT06697184 is currently recruiting participants. This phase1 study for cll is actively seeking new participants at 6 locations across the United States. The study is sponsored by BeiGene. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06697184 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06697184 was last updated Jun 8, 2026 (June 8, 2026). HelloStudys verifies this status automatically.